These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 15035898)

  • 1. Clinical evaluation of "immunoaugmentative therapy (IAT)": an unconventional cancer treatment.
    Pfeifer BL; Jonas WB
    Integr Cancer Ther; 2003 Jun; 2(2):112-9. PubMed ID: 15035898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple dietary antioxidants enhance the efficacy of standard and experimental cancer therapies and decrease their toxicity.
    Prasad KN
    Integr Cancer Ther; 2004 Dec; 3(4):310-22. PubMed ID: 15523102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer outcomes at the Hufeland (complementary/alternative medicine) klinik: a best-case series review.
    Jacobson JS; Grann VR; Gnatt MA; Hibshoosh H; Austin JH; Millar WS; Neugut AI
    Integr Cancer Ther; 2005 Jun; 4(2):156-67. PubMed ID: 15911928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of biochemical recurrence of prostate cancer with granulocyte-macrophage colony-stimulating factor secreting, allogeneic, cellular immunotherapy.
    Urba WJ; Nemunaitis J; Marshall F; Smith DC; Hege KM; Ma J; Nguyen M; Small EJ
    J Urol; 2008 Nov; 180(5):2011-7; discussion 2017-8. PubMed ID: 18801509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of the best case series methodology: best case series results of East-West Cancer Center.
    Yoo HS; Cho CK; Hong MS
    Integr Cancer Ther; 2008 Sep; 7(3):182-8. PubMed ID: 18815149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supraglottic laryngeal cancer: analysis of treatment results.
    Sessions DG; Lenox J; Spector GJ
    Laryngoscope; 2005 Aug; 115(8):1402-10. PubMed ID: 16094113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
    Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
    Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical benefits of epoetin alfa (Eprex) 10,000 units subcutaneously thrice weekly in Thai cancer patients with anemia receiving chemotherapy.
    Voravud N; Sriuranpong V
    J Med Assoc Thai; 2005 May; 88(5):607-12. PubMed ID: 16149676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
    Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T;
    Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy (APC8015, Provenge) targeting prostatic acid phosphatase can induce durable remission of metastatic androgen-independent prostate cancer: a Phase 2 trial.
    Burch PA; Croghan GA; Gastineau DA; Jones LA; Kaur JS; Kylstra JW; Richardson RL; Valone FH; Vuk-Pavlović S
    Prostate; 2004 Aug; 60(3):197-204. PubMed ID: 15176049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five-year survival of patients with hepatocellular carcinoma treated with laparoscopic microwave coagulation therapy.
    Seki S; Sakaguchi H; Iwai S; Kadoya H; Kabayashi S; Kitada T; Fujii H; Tanaka T
    Endoscopy; 2005 Dec; 37(12):1220-5. PubMed ID: 16329021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraarterial therapy for acute ischemic stroke: investigation of prognostic factors.
    Noguchi T; Yoshiura T; Oguri S; Hiwatashi A; Togao O; Yamashita K; Nagao E; Murakami J; Mihara F; Honda H
    Fukuoka Igaku Zasshi; 2007 Aug; 98(8):320-8. PubMed ID: 17907448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of somatostatin analog, dexamethasone, and standard androgen ablation therapy in stage D3 prostate cancer patients with bone metastases.
    Koutsilieris M; Mitsiades CS; Bogdanos J; Dimopoulos T; Karamanolakis D; Milathianakis C; Tsintavis A
    Clin Cancer Res; 2004 Jul; 10(13):4398-405. PubMed ID: 15240528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Qualitative analysis of cancer patients' experiences using donated human milk.
    Rough SM; Sakamoto P; Fee CH; Hollenbeck CB
    J Hum Lact; 2009 May; 25(2):211-9. PubMed ID: 19414823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vinorelbine, doxorubicin, and prednisone in androgen-independent prostate cancer.
    Borden LS; Clark PE; Lovato J; Hall MC; Stindt D; Harmon M; M Mohler R; Torti FM
    Cancer; 2006 Sep; 107(5):1093-100. PubMed ID: 16888761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment delay and prognosis in invasive bladder cancer.
    Liedberg F; Anderson H; Månsson W
    J Urol; 2005 Nov; 174(5):1777-81; discussion 1781. PubMed ID: 16217282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oregovomab maintenance monoimmunotherapy does not improve outcomes in advanced ovarian cancer.
    Berek J; Taylor P; McGuire W; Smith LM; Schultes B; Nicodemus CF
    J Clin Oncol; 2009 Jan; 27(3):418-25. PubMed ID: 19075271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II study of picoplatin as second-line therapy for patients with small-cell lung cancer.
    Eckardt JR; Bentsion DL; Lipatov ON; Polyakov IS; Mackintosh FR; Karlin DA; Baker GS; Breitz HB
    J Clin Oncol; 2009 Apr; 27(12):2046-51. PubMed ID: 19289620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunotherapy in radical surgery of colorectal carcinoma].
    Brivio F; Fumagalli L; Chiarelli M; Denova M; Bertolini A; Cetta M; Nespoli A
    Chir Ital; 2007; 59(5):635-40. PubMed ID: 18019635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.